News – VivaZome Therapeutics

Latest news and media releases

Craig Newton
September 16, 2025
3:54 pm
0 comments

VivaZome shares EV Manufacturing insights at 2025 Bio Processing Conference

This week in Melbourne, VivaZome’s Senior Scientist Johannes Weber presented a poster entitled “Process Development for Scalable Extracellular Vesicle (EV) Manufacturing” at the 18th Annual Bioprocessing Network Conference. The poster – authored by Johannes Weber, Ella Johnston, Smriti Krishna, Nicole Wasco, Craig Newton, Xenia Sango, Louise White and David Haylock – highlights the challenges and […]

Craig Newton
August 7, 2025
10:52 am
0 comments

VivaZome Scientists Publish Major Review on Customised Extracellular Vesicles (EVs)

7 August 2025, Melbourne, Australia: VivaZome is pleased to announce the publication of a landmark review article in Health Nanotechnology (BMC; Springer Nature) titled “Customised extracellular vesicle therapeutics for neurological conditions” (DOI: 10.1186/s44301-025-00007-3). The paper, authored by Dr. Ella Johnston, VivaZome scientist, and co-authored by Johannes Weber, Xenia Sango (CEO), Dr. Ian Nisbet, and Prof. […]

Craig Newton
July 26, 2025
4:57 pm
0 comments

MACQUARIE UNIVERSITY AND VIVAZOME PUBLISH MICROFLUIDICS REVIEW

VivaZome is delighted to share that a comprehensive review “Microfluidic Devices for Manufacture of Therapeutic Extracellular Vesicles: Advances and Opportunities”, has been published in the Journal of Extracellular Vesicles. The paper is authored by Dr. Amin Hassanzadeh-Barforoushi (lead author) and Professor Yuling Wang from Macquarie University, Sydney and by VivaZome CEO Xenia Sango, CSO Dr. […]

Craig Newton
July 13, 2025
2:26 pm
0 comments

VIVAZOME SCIENTIST AWARDED ARC FELLOWSHIP.

VivaZome Therapeutics is proud to announce that our Research Scientist Dr. Ella Johnston is the recipient of a prestigious ARC Early Career Industry Fellowship in partnership with La Trobe University. The Australian Research Council (ARC) Early Career Industry Fellowship program is designed to foster deep collaboration between early career researchers and industry partners, enabling the […]

Craig Newton
July 12, 2025
3:31 pm
0 comments

VivaZome CEO Presents at Asia’s Leading Bioprocessing Conference

VivaZome Therapeutics is pleased to share that CEO, Xenia Sango, was an invited chair and speaker at the 12th Annual Biologics Manufacturing Asia Conference 2025, held at the Sands Expo & Convention Centre in Singapore. Recognised as Asia’s #1 bioprocessing event, the conference brought together over 1,300 attendees from more than 500 companies across the […]

Craig Newton
July 8, 2025
3:47 pm
0 comments

BUILDING BUSINESS AT BIO IN BOSTON.

In June 2025, VivaZome CEO Xenia Sango and Director Craig Newton attended the world’s largest biotech meeting BIO2025, in Boston, with the support of Global Victoria. A fantastic experience with high-quality presentations, a massive trade exhibition and most usefully, an excellent partnering program. Xenia and Craig had over 40 meetings over the 4 days, including […]

Craig Newton
May 1, 2025
11:30 am
0 comments

VivaZome’s EVs show activity in brain injury models: presented at major conference in Vienna.

VivaZome Therapeutics is delighted to announce that extracellular vesicles (EVs) from its proprietary human cell line have shown promising results in animal models of Traumatic Brain Injury (TBI). These encouraging findings were presented by VivaZome’s Chief Scientific Officer, Professor David Haylock, at the 2025 conference of the International Society of Extracellular Vesicles (ISEV) recently held in Vienna, […]

Craig Newton
March 22, 2024
3:04 pm
0 comments

VivaZome and La Trobe University to collaborate on EVs for stroke treatment

20 March 2024, Melbourne, Australia: VivaZome Therapeutics Pty Ltd and La Trobe University are pleased to announce that they will be collaborating to explore the therapeutic potential for VivaZome’s extracellular vesicles (EVs) in models of stroke in the laboratory of Professor Chris Sobey (pictured). This collaborative effort brings together VivaZome’s expertise in EV manufacturing and […]

Craig Newton
November 10, 2023
11:20 am
0 comments

VivaZome presents on exosome purification, customisation and manufacturing at ANZSEV

VivaZome Therapeutics is pleased to announce that three posters highlighting the company’s strategies and technologies for exosome purification, customisation and manufacturing of extracellular vesicles (“EVs) are being presented at the 6th annual meeting of the Australian and New Zealand Society of Extracellular Vesicles (“ANZSEV”) this week in the Barossa Valley, South Australia. Dr David Haylock, […]

Craig Newton
September 4, 2023
11:08 pm
0 comments

VivaZome enhances Board and Executive Team

VivaZome is delighted to announce a suite of positive changes to the company’s board and executive team. Xenia Sango has been promoted to CEO and Managing Director, David Haylock has been appointed as Chief Scientific Officer. and Dr Anthony Filippis has joined the Board as Non-Executive Director. See attached release here (The photo shows Xenia […]

Craig Newton
June 13, 2023
4:27 pm
0 comments

ANU Retinal Disease expert joins VivaZome on Industry Fellowship

VivaZome is delighted that Associate Professor Riccardo Natoli from Australian National University (ANU) will be doing an Industry placement with VivaZome in the second half of this year. This placement is supported by the Bridge and BridgeTech Industry Fellowships Program, which is part of MTPConnect’s $32 million REDI initiative. Riccardo’s application was selected from a very competitive […]

Craig Newton
May 18, 2023
8:15 pm
0 comments

VivaZome and collaborators at UQ and ANU present new data at ISEV international exosome conference

VivaZome is delighted to announce that two posters with new mice data highlighting the functional potential of extracellular vesicles (“EVs”) will be presented at the annual meeting of the International Society of Extracellular Vesicles (“ISEV”) held on 17-21 May 2023 in Seattle, USA. The poster, “Local administration of extracellular vesicles from bone marrow-derived mesenchymal stem […]

Craig Newton
January 25, 2023
11:14 pm
0 comments

VivaZome and partners secure $3m CRC-P grant for customised exosomes

VivaZome is delighted to have been awarded an Australian Government Round 13 CRC-P grant of $3.0m in support of the 3-year project “Customised exosomes – the future of regenerative medicine”. Joining VivaZome in the CRC-P are five exceptional Australian project partners – La Trobe University, The University of Queensland, Australian National University, Cytiva and SeerPharma. […]

Craig Newton
November 4, 2022
2:28 pm
0 comments

VivaZome to present at ANZSEV Conference

VivaZome’s Head of Regulatory and Clinical, Ms. Xenia Sango, is an invited speaker at the 5th Conference of the Australia and New Zealand Society for Extracellular Vesicles (ANZSEV) to be held in Gold Coast, Queensland on 9-11 November 2022. Xenia’s will present “Regulatory Affairs Relating to EV-based Therapeutics”. In addition, VivaZome’s CEO, Dr. David Haylock, […]

Craig Newton
May 24, 2022
12:26 pm
0 comments

VivaZome to collaborate with UQ Traumatic Brain Injury experts to develop exosome-based therapies

VivaZome Therapeutics Pty Ltd has entered into a Memorandum of Understanding (MoU) with The University of Queensland (UQ) focussing on improved therapies for Traumatic Brain Injury (TBI) and post-traumatic epileptogenesis (PTE). TBI afflicts close to 69 million people globally. Under the MoU, VivaZome will collaborate with Professor David Reutens – Director of the Centre for […]

Craig Newton
February 2, 2022
11:11 am
0 comments

VivaZome wins Cytiva ANZ BioChallenge 2022

VivaZome Therapeutics has been awarded the top prize in the 2022 Cytiva BioChallenge for the Australia and NewZealand region. The prize, valued at approximately AUD $200,000, will further assist VivaZome in its quest to develop off-the-shelf regenerative medicines. Part of Cytiva’s BioChallenge global series, the inaugural challenge for the ANZ region received 32 applications from […]

Craig Newton
January 27, 2022
1:25 pm
0 comments

VivaZome to collaborate with ANU retinal disease experts to develop exosome-based therapies

VivaZome Therapeutics Pty Ltd is delighted to be collaborating with researchers at the Australian National University (ANU) and other expert groups focussing on improved therapies for age-related macular degeneration (AMD). The project entitled “The use of extracellular vesicles (EVs) for therapeutic RNA delivery as a novel treatment for retinal degenerations” is supported by a grant […]

Craig Newton
May 25, 2021
12:09 pm
0 comments

VivaZome and ReNerve to collaborate on nerve repair

ReNerve and VivaZome have entered a collaboration to combine their leading scaffold and exosome technologies, skills and experience to explore new solutions for the repair of spinal cord injuries. The two companies will work together to explore the potential of combining the ReNerve NervAlign® nerve cuff with VivaZome’s proprietary exosomes to enhance nerve regrowth in […]